Primary Care Intervention Strategy for Anxiety Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

1,004

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Post-traumatic Stress DisorderGeneralized Anxiety DisorderPanic DisorderSocial Anxiety Disorder
Interventions
BEHAVIORAL

Cognitive-behavioral therapy

Participants in CALM will choose to receive CBT, medication, or both for the treatment of their anxiety. CBT includes computer-assisted CBT with an anxiety clinical specialist.

DRUG

Psychotropic medication optimization

For those participants in CALM who choose medication, the ACS will facilitate the delivery of, and adherence to, anti-anxiety medication which will be prescribed by the participants' PCP.

BEHAVIORAL

Treatment as Usual

Participants in the control group will receive standard treatment from their PCP.

Trial Locations (4)

72114

University of Arkansas for Medical Sciences, Little Rock

98104

University of Washington, Seattle

92037-0603

University of California, La Jolla

90095-1563

University of California, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Washington

OTHER

NCT00347269 - Primary Care Intervention Strategy for Anxiety Disorders | Biotech Hunter | Biotech Hunter